FdaApplication
BLA 021536
Identifiers
- fda_app_no: BLA021536
Properties
| Property | Value |
|---|---|
| applicant_name | Novo Nordisk Inc. |
| application_type | BLA |
| approval_date | 2005-06-16 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVEMIR | INSULIN DETEMIR RECOMBINANT | 1,000UNITS/10ML (100UNITS/ML) | Injection |
| LEVEMIR | INSULIN DETEMIR RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
| LEVEMIR | INSULIN DETEMIR RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
| LEVEMIR | INSULIN DETEMIR RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
| LEVEMIR | INSULIN DETEMIR RECOMBINANT | 300UNITS/3ML (100UNITS/ML) | Injection |
5 products